Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

’Disappearing’ tumour study could lead to new cancer treatments

04.06.2003


A research study at The University of Nottingham looking at how growth can contribute to spontaneous childhood cancer regression could lead to more effective ways of treating tumours.



The one-year project, led by Christopher Jones in the School of Nursing in collaboration with Dr Michael Symonds in the Division of Child Health and Dr David Walker at the University’s Children’s Brain Tumour Research Centre, will look at whether growth hormone plays a part in tumours spontaneously getting better.

The researchers are looking at neuroblastoma, which accounts for around six per cent of all childhood cancers. Around 100 children develop neuroblastoma each year in the UK and most of these are less than four years of age.


In around three-quarters of these cases the cancer spreads around the body and the current survival rates are only around 30 per cent.

However, when a tumour of this kind occurs in the liver, particularly in the first year of life, it is only fatal in between 10 and 20 per cent of sufferers and, in many cases, spontaneously regresses without the need for treatment.

Scientists have been studying this medical phenomenon for many years, although most research has centred on looking at the biology of the tumour in an effort to discover why it self-destructs.

The Nottingham researchers, however, believe it could be something within the body and not the tumour itself that sparks off this regression and think that it could be due to the release of hormones that control growth in infancy.

Dr Michael Symonds said: "We believe that spontaneous tumour regression is linked to unique changes within the liver in early childhood, which coincide with the onset of growth hormone-dependent growth."

It is hoped that the study, funded with £7,000 from the Special Trustees of Nottingham University Hospital, will attract more funding for the study of childhood cancers and could even lead to more effective treatments for non-regressing neuroblastoma, as well as other aggressive tumours such as breast cancer and certain types of childhood brain tumours.

Lyn Heath-Harvey | alfa
Further information:
http://www.nottingham.ac.uk/public-affairs/index.html

More articles from Health and Medicine:

nachricht Spread of deadly eye cancer halted in cells and animals
13.11.2018 | Johns Hopkins Medicine

nachricht Breakthrough in understanding how deadly pneumococcus avoids immune defenses
13.11.2018 | University of Liverpool

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

Im Focus: Coping with errors in the quantum age

Physicists at ETH Zurich demonstrate how errors that occur during the manipulation of quantum system can be monitored and corrected on the fly

The field of quantum computation has seen tremendous progress in recent years. Bit by bit, quantum devices start to challenge conventional computers, at least...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

The dawn of a new era for genebanks - molecular characterisation of an entire genebank collection

13.11.2018 | Life Sciences

Fish recognize their prey by electric colors

13.11.2018 | Life Sciences

Ultrasound Connects

13.11.2018 | Awards Funding

VideoLinks
Science & Research
Overview of more VideoLinks >>>